Bone / Cartilage · Bone / cartilage biology peptide · OSTP-020
Calcitonin Gene Related Peptide (8-37), human
- Drug class
- Bone / cartilage biology peptide
- Status
- Research use only
- Catalog code
- OSTP-020
- Also known as
- OSTP-020
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What Calcitonin Gene Related Peptide (8-37), human is studied for
- Osteoblast / osteoclast differentiation assays
- Chondrocyte and cartilage-explant remodeling studies
- Bone-resorption and mineralization models
- Biomaterial functionalization for orthopaedic scaffolds
Mechanism of action
Calcitonin Gene Related Peptide (8-37), human sits within the Bone / Cartilage research class (CPC reference OSTP-020). These peptides interact with bone- and cartilage-relevant receptors and matrix proteins — including RANK/RANKL, PTH1R, integrins, and collagen-binding motifs — modulating osteoblast, osteoclast, and chondrocyte activity in cellular and organ-culture models. Investigators typically incorporate Calcitonin Gene Related Peptide (8-37), human as a reference standard, tool ligand, or substrate in the assay contexts listed above. Commonly paired with ALP, TRAP, or Alizarin Red staining in cell-based readouts.
Frequently asked questions
What is Calcitonin Gene Related Peptide (8-37), human?
Calcitonin Gene Related Peptide (8-37), human (CPC catalog code OSTP-020) is a synthetic bone / cartilage biology peptide in the bone / cartilage category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
What is Calcitonin Gene Related Peptide (8-37), human studied for?
Published and internal research programs use Calcitonin Gene Related Peptide (8-37), human as a reference standard in bone / cartilage workflows — for example, osteoblast / osteoclast differentiation assays and chondrocyte and cartilage-explant remodeling studies. Human clinical evidence is not established.
Is Calcitonin Gene Related Peptide (8-37), human FDA-approved for human use?
No. Calcitonin Gene Related Peptide (8-37), human is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
How is Calcitonin Gene Related Peptide (8-37), human typically used in the lab?
In a bone / cartilage workflow, Calcitonin Gene Related Peptide (8-37), human is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Commonly paired with ALP, TRAP, or Alizarin Red staining in cell-based readouts.
How should Calcitonin Gene Related Peptide (8-37), human be stored?
Store lyophilized at −20 °C. Reconstitute in sterile buffer immediately before use. Follow your institution's standard operating procedures for handling synthetic peptides.
Where does the Calcitonin Gene Related Peptide (8-37), human product page point to?
This kindr reference page mirrors CPC Scientific's catalog metadata for OSTP-020. The upstream reference sheet — including sequence, purity, MW, and application notes where published — is linked from the buy panel. All orders placed on kindr Peptides ship internationally under research-use terms only.
What quality specifications apply to Calcitonin Gene Related Peptide (8-37), human?
Research-grade peptides in the CPC catalog are synthesized by solid-phase peptide synthesis (SPPS), purified by preparative RP-HPLC, and characterized by analytical HPLC and mass spectrometry. Typical purity is ≥95%; certificate of analysis is available on request.
Related peptides in Bone / Cartilage
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- Is HRT safe?Journal
- When to start HRTJournal
- Menopause HRT serviceMedication
- Complete menopause guideJournal
